The Gateway to Study Startup (SSU) Optimization: Performance Metrics
Standardized performance metrics that are actionable drive transparency and process improvement
The sharpening focus on quality management is fueling greater use of standardized metrics to optimize clinical trial performance. But just because data from disparate sources can now be aggregated does not necessarily mean that this information or the resulting metrics are actionable, or can identify risk proactively. That's why targeted performance metrics that measure the many details of clinical trial operations are essential. And for study startup (SSU) in particular, performance metrics are critical, given that it is one of the most complicated parts of clinical trials and one of the most crucial to meeting site activation timelines and study completion milestones.
Each of the SSU tasks is composed of multiple steps, and performance metrics are needed to evaluate them at a granular level, all in an effort to spot bottlenecks and identify processes ripe for optimization. The information revealed by tracking all the sub-steps in near real-time fashion is in stark contrast to what is provided by so-called regulatory metrics, which are generated from data entered into the TMF, and are auditable. Typically, regulatory metrics are "high level", meaning that they do not measure each of the sub-steps, but rather track all-inclusive milestones. There is a lack of business intelligence with this approach, forcing stakeholders into reactive mode, since the information does not pinpoint which sub-steps are problematic and only becomes available after milestones are achieved.
Download our white paper "The Gateway to Study Startup (SSU) Optimization: Performance Metrics" to learn about how standardized performance metrics designed to measure various sub-steps help to optimize the SSU process by providing transparency into bottlenecks that could derail study activation, cycle times and budgets.
Fill out the form to get your copy today!